BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18813360)

  • 1. Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization.
    Zhu Q; Tannenbaum S; Hegde P; Kane M; Xu C; Kurtzman SH
    Neoplasia; 2008 Oct; 10(10):1028-40. PubMed ID: 18813360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis.
    Tran WT; Gangeh MJ; Sannachi L; Chin L; Watkins E; Bruni SG; Rastegar RF; Curpen B; Trudeau M; Gandhi S; Yaffe M; Slodkowska E; Childs C; Sadeghi-Naini A; Czarnota GJ
    Br J Cancer; 2017 May; 116(10):1329-1339. PubMed ID: 28419079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer.
    Guarneri V; Pecchi A; Piacentini F; Barbieri E; Dieci MV; Ficarra G; Tazzioli G; Frassoldati A; Battista R; Canossi B; Mauri C; D'Amico R; Conte P; Torricelli P
    Ann Surg Oncol; 2011 Aug; 18(8):2150-7. PubMed ID: 21301969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography.
    Zhu Q; DeFusco PA; Ricci A; Cronin EB; Hegde PU; Kane M; Tavakoli B; Xu Y; Hart J; Tannenbaum SH
    Radiology; 2013 Feb; 266(2):433-42. PubMed ID: 23264349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of evaluating tumor vascularization using 3D power Doppler ultrasound with high-definition flow technology in the prediction of the response to neoadjuvant chemotherapy for T2 breast cancer: a preliminary report.
    Shia WC; Chen DR; Huang YL; Wu HK; Kuo SJ
    Phys Med Biol; 2015 Oct; 60(19):7763-78. PubMed ID: 26393306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer.
    Ma Y; Zhang S; Zang L; Li J; Li J; Kang Y; Ren W
    Eur J Cancer; 2016 Dec; 69():86-101. PubMed ID: 27821323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective trial of breast MRI versus 2D and 3D ultrasound for evaluation of response to neoadjuvant chemotherapy.
    Lee MC; Gonzalez SJ; Lin H; Zhao X; Kiluk JV; Laronga C; Mooney B
    Ann Surg Oncol; 2015 Sep; 22(9):2888-94. PubMed ID: 25589151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
    Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
    J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
    Schaafsma BE; van de Giessen M; Charehbili A; Smit VT; Kroep JR; Lelieveldt BP; Liefers GJ; Chan A; Löwik CW; Dijkstra J; van de Velde CJ; Wasser MN; Vahrmeijer AL
    Clin Cancer Res; 2015 Feb; 21(3):577-84. PubMed ID: 25473002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic response prediction to neoadjuvant chemotherapy utilizing pretreatment near-infrared imaging parameters and tumor pathologic criteria.
    Zhu Q; Wang L; Tannenbaum S; Ricci A; DeFusco P; Hegde P
    Breast Cancer Res; 2014 Oct; 16(5):456. PubMed ID: 25349073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI in the evaluation of breast cancer patient response to neoadjuvant chemotherapy: predictive factors for breast conservative surgery.
    Nadrljanski MM; Miloševic ZC; Plešinac-Karapandžic V; Maksimovic R
    Diagn Interv Radiol; 2013; 19(6):463-70. PubMed ID: 24047722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy.
    Amioka A; Masumoto N; Gouda N; Kajitani K; Shigematsu H; Emi A; Kadoya T; Okada M
    Jpn J Clin Oncol; 2016 Apr; 46(4):303-9. PubMed ID: 26848078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-Guided Diffuse Optical Tomography for Predicting and Monitoring Neoadjuvant Chemotherapy of Breast Cancers: Recent Progress.
    Xu C; Vavadi H; Merkulov A; Li H; Erfanzadeh M; Mostafa A; Gong Y; Salehi H; Tannenbaum S; Zhu Q
    Ultrason Imaging; 2016 Jan; 38(1):5-18. PubMed ID: 25887527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer.
    Goorts B; Dreuning KMA; Houwers JB; Kooreman LFS; Boerma EG; Mann RM; Lobbes MBI; Smidt ML
    Breast Cancer Res; 2018 Apr; 20(1):34. PubMed ID: 29669584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.
    Akazawa K; Tamaki Y; Taguchi T; Tanji Y; Miyoshi Y; Kim SJ; Ueda S; Yanagisawa T; Sato Y; Tamura S; Noguchi S
    Breast J; 2006; 12(2):130-7. PubMed ID: 16509837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer.
    Cao X; Xue J; Zhao B
    Ultrasound Med Biol; 2012 Dec; 38(12):2065-71. PubMed ID: 23062366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of factors that influence the accuracy of magnetic resonance imaging for predicting response after neoadjuvant chemotherapy in locally advanced breast cancer.
    Ko ES; Han BK; Kim RB; Ko EY; Shin JH; Hahn SY; Nam SJ; Lee JE; Lee SK; Im YH; Park YH
    Ann Surg Oncol; 2013 Aug; 20(8):2562-8. PubMed ID: 23463090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of PET CT to evaluate the response to neoadjuvant chemotherapy in advanced breast cancer: comparison with ultrasonography and magnetic resonance imaging.
    Choi JH; Lim HI; Lee SK; Kim WW; Kim SM; Cho E; Ko EY; Han BK; Park YH; Ahn JS; Im YH; Lee JE; Yang JH; Nam SJ
    J Surg Oncol; 2010 Oct; 102(5):392-7. PubMed ID: 19877158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment.
    Rubio IT; Esgueva-Colmenarejo A; Espinosa-Bravo M; Salazar JP; Miranda I; Peg V
    Ann Surg Oncol; 2016 Jan; 23(1):38-43. PubMed ID: 26514120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical tomography with ultrasound localization for breast cancer diagnosis and treatment monitoring.
    Zhu Q; Tannenbaum S; Kurtzman SH
    Surg Oncol Clin N Am; 2007 Apr; 16(2):307-21. PubMed ID: 17560514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.